|
1 Indications And Usage Vascepa ® (Icosapent Ethyl) Is Indicated: As An Adjunct To Maximally Tolerated Statin Therapy To Reduce The Risk Of Myocardial Infarction, Stroke, Coronary Revascularization, And Unstable Angina Requiring Hospitalization In Adult Patients With Elevated Triglyceride (Tg) Levels (≥ 150 Mg/dl) And Established Cardiovascular Disease Or Diabetes Mellitus And 2 Or More Additional Risk Factors For Cardiovascular Disease. As An Adjunct To Diet To Reduce Tg Levels In Adult Patients With Severe (≥ 500 Mg/dl) Hypertriglyceridemia. Limitations Of Use: The Effect Of Vascepa On The Risk For Pancreatitis In Patients With Severe Hypertriglyceridemia Has Not Been Determined. Vascepa Is An Ethyl Ester Of Eicosapentaenoic Acid (Epa) Indicated: As An Adjunct To Maximally Tolerated Statin Therapy To Reduce The Risk Of Myocardial Infarction, Stroke, Coronary Revascularization, And Unstable Angina Requiring Hospitalization In Adult Patients With Elevated Triglyceride (Tg) Levels (≥ 150 Mg/dl) And Established Cardiovascular Disease Or Diabetes Mellitus And 2 Or More Additional Risk Factors For Cardiovascular Disease. ( 1 ) As An Adjunct To Diet To Reduce Tg Levels In Adult Patients With Severe (≥ 500 Mg/dl) Hypertriglyceridemia. ( 1 ) Limitations Of Use: The Effect Of Vascepa On The Risk For Pancreatitis In Patients With Severe Hypertriglyceridemia Has Not Been Determined. ( 1 )
|